Literature DB >> 30148677

Hypoxic preconditioning attenuates necroptotic neuronal death induced by global cerebral ischemia via Drp1-dependent signaling pathway mediated by CaMKIIα inactivation in adult rats.

Lixuan Zhan1,2,3, Zhiwei Lu1,2,3,4, Xinyong Zhu1,2,3, Wensheng Xu1,2,3, Luxi Li1,2,3, Xinyu Li1,2,3, Siyuan Chen1,2,3, Weiwen Sun1,2,3, En Xu1,2,3.   

Abstract

Hypoxic preconditioning (HPC) alleviates the selective and delayed neuronal death in the hippocampal CA1 region induced by transient global cerebral ischemia (tGCI). This type of cell death may include different programmed cell death mechanisms, namely, apoptosis and necroptosis. Although apoptotic signaling is well defined, the mechanisms that underlie neuronal necroptosis are yet to be fully elucidated. In this study, we investigated whether HPC protects neurons from cerebral ischemia-induced necroptosis. We observed that tGCI up-regulated the expression of receptor-interacting protein (RIP) 3 and increased the interaction of RIP1-RIP3 in CA1 at the early stage of reperfusion. The pretreatment with HPC or necrostatin-1 decreased the expression of RIP3 and the formation of RIP1-RIP3 after tGCI. We also found that HPC decreased the expression and the activity of caspase-8 in CA1 after tGCI, and notably, the pretreatment with Z-VAD-FMK, a pan-caspase inhibitor, did not trigger necroptosis but attenuated the tGCI-induced neuronal damage. Furthermore, we demonstrated that HPC decreased the activation of calcium-calmodulin kinase (CaMK) IIα and the interaction of RIP1 and CaMKIIα induced by tGCI. Intriguingly, the pretreatment with a CaMKs inhibitor KN-93 before tGCI resulted in significantly reduced RIP1-3 interaction and tGCI-induced neuronal damage. Finally, we ascertained that HPC prevented the dephosphorylation of dynamin-related protein 1 (Drp1)-Ser637 (serine 637) and inhibited the translocation of Drp1 to mitochondria induced by tGCI. Importantly, the treatment with a Drp1 inhibitor Mdivi-1 or necrostatin-1 before tGCI also abolished Drp1 dephosphorylation at Ser637 and mitochondrial translocation. Taken together, our results highlight that HPC attenuates necroptotic neuronal death induced by tGCI via Drp1-dependent mitochondrial signaling pathways mediated by CaMKIIα inactivation.-Zhan, L., Lu, Z., Zhu, X., Xu, W., Li, L., Li, X., Chen, S., Sun, W., Xu, E. Hypoxic preconditioning attenuates necroptotic neuronal death induced by global cerebral ischemia via Drp1-dependent signaling pathway mediated by CaMKIIα inactivation in adult rats.

Entities:  

Keywords:  apoptosis; dynamin-related protein 1; ischemic tolerance; necroptosis

Mesh:

Substances:

Year:  2018        PMID: 30148677     DOI: 10.1096/fj.201800111RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  15 in total

1.  Rbfox-1 contributes to CaMKIIα expression and intracerebral hemorrhage-induced secondary brain injury via blocking micro-RNA-124.

Authors:  Fang Shen; Xiang Xu; Zhengquan Yu; Haiying Li; Haitao Shen; Xiang Li; Meifen Shen; Gang Chen
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-04       Impact factor: 6.200

Review 2.  The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic/reperfusion of cardiac injury.

Authors:  Leonid N Maslov; Sergey V Popov; Natalia V Naryzhnaya; Alexandr V Mukhomedzyanov; Boris K Kurbatov; Ivan A Derkachev; Alla A Boshchenko; Igor Khaliulin; N Rajendra Prasad; Nirmal Singh; Alexei Degterev; Evgenia A Tomilova; Ekaterina V Sapozhenkova
Journal:  Apoptosis       Date:  2022-08-20       Impact factor: 5.561

Review 3.  Cell Death Mechanisms in Cerebral Ischemia-Reperfusion Injury.

Authors:  Qian Zhang; Meng Jia; YunFu Wang; Qun Wang; Jianping Wu
Journal:  Neurochem Res       Date:  2022-08-17       Impact factor: 4.414

4.  An apoptosis inhibitor suppresses microglial and astrocytic activation after cardiac ischemia/reperfusion injury.

Authors:  Suchan Liao; Ying Luo; Titikorn Chunchai; Kodchanan Singhanat; Busarin Arunsak; Juthipong Benjanuwattra; Nattayaporn Apaijai; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Inflamm Res       Date:  2022-06-02       Impact factor: 6.986

5.  Inhibition of MLKL-dependent necroptosis via downregulating interleukin-1R1 contributes to neuroprotection of hypoxic preconditioning in transient global cerebral ischemic rats.

Authors:  Lixuan Zhan; Xiaomei Lu; Wensheng Xu; Weiwen Sun; En Xu
Journal:  J Neuroinflammation       Date:  2021-04-20       Impact factor: 8.322

6.  Pre- and Post-Treatment with Novel Antiepileptic Drug Oxcarbazepine Exerts Neuroprotective Effect in the Hippocampus in a Gerbil Model of Transient Global Cerebral Ischemia.

Authors:  Ji Hyeon Ahn; Bich Na Shin; Joon Ha Park; Tae-Kyeong Lee; Young Eun Park; Jae-Chul Lee; Go Eun Yang; Myoung Cheol Shin; Jun Hwi Cho; Kyu Chang Lee; Moo-Ho Won; Hyeyoung Kim
Journal:  Brain Sci       Date:  2019-10-17

7.  Neuroprotective Effects of Necrostatin-1 Against Oxidative Stress-Induced Cell Damage: an Involvement of Cathepsin D Inhibition.

Authors:  Danuta Jantas; Jakub Chwastek; Beata Grygier; Władysław Lasoń
Journal:  Neurotox Res       Date:  2020-01-21       Impact factor: 3.911

Review 8.  Coordination between Calcium/Calmodulin-Dependent Protein Kinase II and Neuronal Nitric Oxide Synthase in Neurons.

Authors:  Shoma Araki; Koji Osuka; Tsuyoshi Takata; Yukihiro Tsuchiya; Yasuo Watanabe
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

9.  Mdivi-1 attenuates oxidative stress and exerts vascular protection in ischemic/hypoxic injury by a mechanism independent of Drp1 GTPase activity.

Authors:  Chenyang Duan; Li Wang; Jie Zhang; Xinming Xiang; Yue Wu; Zisen Zhang; Qinghui Li; Kunlun Tian; Mingying Xue; Liangming Liu; Tao Li
Journal:  Redox Biol       Date:  2020-08-29       Impact factor: 11.799

Review 10.  Neuroprotective effects and mechanisms of ischemic/hypoxic preconditioning on neurological diseases.

Authors:  Jia Liu; Yakun Gu; Mengyuan Guo; Xunming Ji
Journal:  CNS Neurosci Ther       Date:  2021-08       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.